Operating Expenses
Lease Costs
Vertex Pharmaceuticals Lease Costs remained flat by 0.0% to $64.38M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 27.5%, from $50.50M to $64.38M. Over 2 years (FY 2023 to FY 2025), Lease Costs shows an upward trend with a 22.6% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Increasing lease costs may indicate expansion or a shift toward an asset-light strategy, while decreasing costs could signal consolidation or a shift toward asset ownership.
Detailed definition
This metric aggregates the total expenses incurred from leasing arrangements, including operating lease payments, variab...
Peer comparison
Standard across all sectors; peers report this under operating expenses, often broken down in lease-specific disclosures.
Metric ID:
wfc_lease_costsHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $171.20M | $202.00M | $257.50M |
| YoY Change | — | +18.0% | +27.5% |
Range$171.20M – $257.50M
CAGR+22.6%
Avg YoY Growth+22.7%
Median YoY Growth+22.7%
Current Streak2+ years growth
Lease Costs at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's lease costs?
- Vertex Pharmaceuticals (VRTX) reported lease costs of $64.38M in Q4 2025.
- How has Vertex Pharmaceuticals's lease costs changed year-over-year?
- Vertex Pharmaceuticals's lease costs increased by 27.5% year-over-year, from $50.50M to $64.38M.
- What is the long-term trend for Vertex Pharmaceuticals's lease costs?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's lease costs has grown at a 22.6% compound annual growth rate (CAGR), from $171.20M to $257.50M.
- What does lease costs mean?
- The total expense recognized for renting or leasing assets.